Drgonova Jana, Walther Donna, Hartstein G Luke, Bukhari Mohammad O, Baumann Michael H, Katz Jonathan, Hall Frank Scott, Arnold Elizabeth R, Flax Shaun, Riley Anthony, Rivero-Martin Olga, Lesch Klaus-Peter, Troncoso Juan, Ranscht Barbara, Uhl George R
Molecular Neurobiology, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Medicinal Chemistry, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Mol Med. 2016 Oct;22:537-547. doi: 10.2119/molmed.2015.00170. Epub 2016 Aug 18.
The cadherin 13 (CDH13) gene encodes a cell adhesion molecule likely to influence development and connections of brain circuits that modulate addiction, locomotion and cognition, including those that involve midbrain dopamine neurons. Human CDH13 mRNA expression differs by more than 80% in postmortem cerebral cortical samples from individuals with different CDH13 genotypes, supporting examination of mice with altered Cdh13 expression as models for common human variation at this locus. Constitutive cdh13 knockout mice display evidence for changed cocaine reward: shifted dose response relationship in tests of cocaine-conditioned place preference using doses that do not alter cocaine conditioned taste aversion. Reduced adult Cdh13 expression in conditional knockouts also alters cocaine reward in ways that correlate with individual differences in cortical Cdh13 mRNA levels. In control and comparison behavioral assessments, knockout mice display modestly-quicker acquisition of rotarod and water maze tasks, with a trend toward faster acquisition of 5 choice serial reaction time tasks that otherwise displayed no genotype-related differences. They display significant differences in locomotion in some settings, with larger effects in males. In assessments of brain changes that might contribute to these behavioral differences, there are selective alterations of dopamine levels, dopamine/metabolite ratios, dopaminergic fiber densities and mRNA encoding the activity dependent transcription factor in cerebral cortex of knockout mice. These novel data and previously reported human associations of CDH13 variants with addiction, individual differences in responses to stimulant administration and attention deficit hyperactivity disorder (ADHD) phenotypes suggest that levels of CDH13 expression, through mechanisms likely to include effects on mesocortical dopamine, influence stimulant reward and may contribute modestly to cognitive and locomotor phenotypes relevant to ADHD.
钙黏蛋白13(CDH13)基因编码一种细胞黏附分子,可能影响调节成瘾、运动和认知的脑回路的发育及连接,包括那些涉及中脑多巴胺神经元的脑回路。在来自具有不同CDH13基因型个体的死后大脑皮质样本中,人类CDH13 mRNA表达差异超过80%,这支持了将Cdh13表达改变的小鼠作为该基因座常见人类变异模型进行研究。组成型Cdh13基因敲除小鼠显示出可卡因奖赏改变的证据:在使用不改变可卡因条件性味觉厌恶的剂量进行可卡因条件性位置偏爱测试中,剂量反应关系发生了改变。条件性基因敲除小鼠中成年Cdh13表达的降低也以与皮质Cdh13 mRNA水平个体差异相关的方式改变了可卡因奖赏。在对照和比较行为评估中,基因敲除小鼠在转棒和水迷宫任务中表现出适度更快的习得,在5选连续反应时任务的习得方面有更快的趋势,而在其他方面未显示出基因型相关差异。在某些情况下,它们在运动方面表现出显著差异,对雄性的影响更大。在对可能导致这些行为差异的大脑变化的评估中,基因敲除小鼠大脑皮质中的多巴胺水平、多巴胺/代谢物比率、多巴胺能纤维密度以及编码活性依赖性转录因子的mRNA存在选择性改变。这些新数据以及先前报道的CDH13变体与成瘾、对兴奋剂给药反应的个体差异和注意力缺陷多动障碍(ADHD)表型的人类关联表明,CDH13的表达水平可能通过包括对中脑皮质多巴胺的影响等机制,影响兴奋剂奖赏,并可能对与ADHD相关的认知和运动表型有一定贡献。